⌘K

Login Start Free

Home/Filings/4/0001144204-16-076485

4//SEC Filing

CASI Pharmaceuticals, Inc. 4

Accession 0001144204-16-076485

CIK 0000895051operating

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 3:55 PM ET

Size

9.0 KB

Accession

0001144204-16-076485

Insider Transaction Report

Form 4

Period: 2016-01-19

CASI Pharmaceuticals, Inc.CASI

Chief Executive Officer

Transactions

Purchase
Common Stock
2016-01-19$0.74/sh+1,100$814→ 8,637 total
Purchase
Common Stock
2016-01-19$0.72/sh+6,063$4,365→ 14,700 total
Purchase
Common Stock
2016-01-19$0.73/sh+7,537$5,502→ 7,537 total
Purchase
Common Stock
2016-01-19$0.71/sh+300$213→ 15,000 total

Documents

1 file

4
v429400_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000895051

Filing Metadata

Form type: 4
Filed: Jan 20, 7:00 PM ET
Accepted: Jan 21, 3:55 PM ET
Size: 9.0 KB

View on SEC.gov